Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-09

Clinical Trial Update: A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne [Phase 4]

View source ↗

Summary

Phase 4 trial results assess the efficacy of combining clascoterone 1% cream with adapalene 0.3% for acne vulgaris. The study is completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene 0.3% (adapalene)
  • Clascoterone 1% cream (clascoterone)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2025-10-09